• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CRISPR-Cas9核糖核蛋白的封装递送加速了基因组编辑。

Packaged delivery of CRISPR-Cas9 ribonucleoproteins accelerates genome editing.

作者信息

Karp Hannah, Zoltek Madeline, Wasko Kevin, Vazquez Angel Luis, Brim Jinna, Ngo Wayne, Schepartz Alanna, Doudna Jennifer A

机构信息

Department of Chemistry, University of California, Berkeley, CA 94720, United States.

Innovative Genomics Institute, University of California, Berkeley, CA 94720, United States.

出版信息

Nucleic Acids Res. 2025 Feb 27;53(5). doi: 10.1093/nar/gkaf105.

DOI:10.1093/nar/gkaf105
PMID:40036508
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11878570/
Abstract

Effective genome editing requires a sufficient dose of CRISPR-Cas9 ribonucleoproteins (RNPs) to enter the target cell while minimizing immune responses, off-target editing, and cytotoxicity. Clinical use of Cas9 RNPs currently entails electroporation into cells ex vivo, but no systematic comparison of this method to packaged RNP delivery has been made. Here we compared two delivery strategies, electroporation and enveloped delivery vehicles (EDVs), to investigate the Cas9 dosage requirements for genome editing. Using fluorescence correlation spectroscopy, we determined that >1300 Cas9 RNPs per nucleus are typically required for productive genome editing. EDV-mediated editing was >30-fold more efficient than electroporation, and editing occurs at least 2-fold faster for EDV delivery at comparable total Cas9 RNP doses. We hypothesize that differences in efficacy between these methods result in part from the increased duration of RNP nuclear residence resulting from EDV delivery. Our results directly compare RNP delivery strategies, showing that packaged delivery could dramatically reduce the amount of CRISPR-Cas9 RNPs required for experimental or clinical genome editing.

摘要

有效的基因组编辑需要足够剂量的CRISPR-Cas9核糖核蛋白(RNP)进入靶细胞,同时将免疫反应、脱靶编辑和细胞毒性降至最低。目前,Cas9 RNP的临床应用需要在体外将其电穿孔导入细胞,但尚未对该方法与包装的RNP递送进行系统比较。在此,我们比较了两种递送策略,即电穿孔和包膜递送载体(EDV),以研究基因组编辑所需的Cas9剂量要求。使用荧光相关光谱法,我们确定每个细胞核通常需要>1300个Cas9 RNP才能进行有效的基因组编辑。EDV介导的编辑效率比电穿孔高>30倍,并且在总Cas9 RNP剂量相当的情况下,EDV递送的编辑速度至少快2倍。我们推测,这些方法之间的效率差异部分源于EDV递送导致的RNP核内驻留时间延长。我们的结果直接比较了RNP递送策略,表明包装递送可以显著减少实验性或临床基因组编辑所需的CRISPR-Cas9 RNP的量。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6555/11878570/14c77c05c949/gkaf105fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6555/11878570/24c8312d46ca/gkaf105figgra1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6555/11878570/1d2d3efe6c6a/gkaf105fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6555/11878570/21074d9fc602/gkaf105fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6555/11878570/660addd24ba4/gkaf105fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6555/11878570/14c77c05c949/gkaf105fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6555/11878570/24c8312d46ca/gkaf105figgra1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6555/11878570/1d2d3efe6c6a/gkaf105fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6555/11878570/21074d9fc602/gkaf105fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6555/11878570/660addd24ba4/gkaf105fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6555/11878570/14c77c05c949/gkaf105fig4.jpg

相似文献

1
Packaged delivery of CRISPR-Cas9 ribonucleoproteins accelerates genome editing.CRISPR-Cas9核糖核蛋白的封装递送加速了基因组编辑。
Nucleic Acids Res. 2025 Feb 27;53(5). doi: 10.1093/nar/gkaf105.
2
Packaged delivery of CRISPR-Cas9 ribonucleoproteins accelerates genome editing.CRISPR-Cas9核糖核蛋白的包装递送加速了基因组编辑。
bioRxiv. 2024 Oct 19:2024.10.18.619117. doi: 10.1101/2024.10.18.619117.
3
Mechanism-guided engineering of a minimal biological particle for genome editing.用于基因组编辑的最小生物颗粒的机制引导工程。
Proc Natl Acad Sci U S A. 2025 Jan 7;122(1):e2413519121. doi: 10.1073/pnas.2413519121. Epub 2024 Dec 30.
4
Simplified CRISPR tools for efficient genome editing and streamlined protocols for their delivery into mammalian cells and mouse zygotes.用于高效基因组编辑的简化CRISPR工具及其导入哺乳动物细胞和小鼠受精卵的简化方案。
Methods. 2017 May 15;121-122:16-28. doi: 10.1016/j.ymeth.2017.03.021. Epub 2017 Mar 27.
5
A biodegradable lipid nanoparticle delivers a Cas9 ribonucleoprotein for efficient and safe in situ genome editing in melanoma.一种可生物降解的脂质纳米颗粒递送Cas9核糖核蛋白,用于黑色素瘤中高效且安全的原位基因组编辑。
Acta Biomater. 2024 Dec;190:531-547. doi: 10.1016/j.actbio.2024.10.030. Epub 2024 Oct 25.
6
CRISPR/Cas9 ribonucleoprotein-mediated genome and epigenome editing in mammalian cells.CRISPR/Cas9 核糖核蛋白介导的哺乳动物细胞基因组和表观基因组编辑。
Adv Drug Deliv Rev. 2022 Feb;181:114087. doi: 10.1016/j.addr.2021.114087. Epub 2021 Dec 20.
7
Electroporation-Mediated Delivery of Cas9 Ribonucleoproteins Results in High Levels of Gene Editing in Primary Hepatocytes.电穿孔介导的 Cas9 核糖核蛋白转染可提高原代肝细胞中的基因编辑水平。
CRISPR J. 2022 Jun;5(3):397-409. doi: 10.1089/crispr.2021.0134. Epub 2022 Mar 2.
8
Biomimetic Mineralization-Based CRISPR/Cas9 Ribonucleoprotein Nanoparticles for Gene Editing.基于仿生矿化的 CRISPR/Cas9 核糖核蛋白纳米颗粒用于基因编辑。
ACS Appl Mater Interfaces. 2019 Dec 26;11(51):47762-47770. doi: 10.1021/acsami.9b17598. Epub 2019 Dec 10.
9
Electroporation Delivery of Cas9 sgRNA Ribonucleoprotein-Mediated Genome Editing in Sheep IVF Zygotes.电穿孔递送 Cas9 sgRNA 核糖核蛋白介导的绵羊体外受精胚胎基因组编辑。
Int J Mol Sci. 2024 Aug 23;25(17):9145. doi: 10.3390/ijms25179145.
10
A Guanidinobenzol-Rich Polymer Overcoming Cascade Delivery Barriers for CRISPR-Cas9 Genome Editing.一种富含胍基苯的聚合物,克服 CRISPR-Cas9 基因组编辑的级联传递障碍。
Nano Lett. 2024 Jun 12;24(23):6872-6880. doi: 10.1021/acs.nanolett.4c00533. Epub 2024 Apr 29.

引用本文的文献

1
Morphogenetic Factors as a Tool for Enhancing Plant Regeneration Capacity During In Vitro Transformation.形态发生因子作为体外转化过程中提高植物再生能力的工具
Int J Mol Sci. 2025 Sep 3;26(17):8583. doi: 10.3390/ijms26178583.
2
CRISPR/Cas9 Delivery Systems to Enhance Gene Editing Efficiency.用于提高基因编辑效率的CRISPR/Cas9递送系统。
Int J Mol Sci. 2025 May 6;26(9):4420. doi: 10.3390/ijms26094420.

本文引用的文献

1
Mechanism-guided engineering of a minimal biological particle for genome editing.用于基因组编辑的最小生物颗粒的机制引导工程。
Proc Natl Acad Sci U S A. 2025 Jan 7;122(1):e2413519121. doi: 10.1073/pnas.2413519121. Epub 2024 Dec 30.
2
Evaluation of the correlation between nuclear localization levels and genome editing efficiencies of Cas12a fused with nuclear localization signals.评估与核定位信号融合的Cas12a的核定位水平与基因组编辑效率之间的相关性。
J Pharm Sci. 2025 Feb;114(2):841-848. doi: 10.1016/j.xphs.2024.10.029. Epub 2024 Oct 24.
3
Lung and liver editing by lipid nanoparticle delivery of a stable CRISPR-Cas9 ribonucleoprotein.
通过脂质纳米颗粒递送稳定的CRISPR-Cas9核糖核蛋白对肺和肝脏进行编辑
Nat Biotechnol. 2024 Oct 16. doi: 10.1038/s41587-024-02437-3.
4
Engineered Cas9 variants bypass Keap1-mediated degradation in human cells and enhance epigenome editing efficiency.工程化 Cas9 变体可绕过人类细胞中 Keap1 介导的降解,提高表观基因组编辑效率。
Nucleic Acids Res. 2024 Oct 28;52(19):11536-11551. doi: 10.1093/nar/gkae761.
5
HOPS-Dependent Endosomal Escape Demands Protein Unfolding.依赖HOPS的内体逃逸需要蛋白质解折叠。
ACS Cent Sci. 2024 Mar 26;10(4):860-870. doi: 10.1021/acscentsci.4c00016. eCollection 2024 Apr 24.
6
Optimization of Nuclear Localization Signal Composition Improves CRISPR-Cas12a Editing Rates in Human Primary Cells.核定位信号组成的优化提高了人类原代细胞中的CRISPR-Cas12a编辑率。
GEN Biotechnol. 2022 Jun;1(3):271-284. doi: 10.1089/genbio.2022.0003. Epub 2022 Jun 14.
7
In vivo human T cell engineering with enveloped delivery vehicles.包膜递送载体在体内的人 T 细胞工程。
Nat Biotechnol. 2024 Nov;42(11):1684-1692. doi: 10.1038/s41587-023-02085-z. Epub 2024 Jan 11.
8
Engineered virus-like particles for transient delivery of prime editor ribonucleoprotein complexes in vivo.工程病毒样颗粒用于体内瞬时递呈 Prime 编辑器核糖核蛋白复合物
Nat Biotechnol. 2024 Oct;42(10):1526-1537. doi: 10.1038/s41587-023-02078-y. Epub 2024 Jan 8.
9
Mitigation of chromosome loss in clinical CRISPR-Cas9-engineered T cells.临床 CRISPR-Cas9 基因编辑 T 细胞中染色体丢失的减轻。
Cell. 2023 Oct 12;186(21):4567-4582.e20. doi: 10.1016/j.cell.2023.08.041. Epub 2023 Oct 3.
10
Engineered lentivirus-derived nanoparticles (LVNPs) for delivery of CRISPR/Cas ribonucleoprotein complexes supporting base editing, prime editing and in vivo gene modification.用于递送支持碱基编辑、引导编辑和体内基因修饰的CRISPR/Cas核糖核蛋白复合物的工程化慢病毒衍生纳米颗粒(LVNPs)。
Nucleic Acids Res. 2023 Oct 13;51(18):10059-10074. doi: 10.1093/nar/gkad676.